A phase 3 trial found that Eli Lilly’s tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated with tirzepatide remained diabetes-free by the end of …
The FDA continues to face significant staffing shortages in its drug inspection workforce, according to a new report from the Government Accountability Office.
Tyler, Texas-based Christus Mother Frances Hospital had the lowest unplanned readmission rate for coronary artery bypass graft surgery in the U.S. between July 1, 2020, and July 30, 2023, according to CMS data released Oct. 30.